Skip to main
LTRN
LTRN logo

Lantern Pharma (LTRN)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Lantern Pharma (LTRN) Stock

About Lantern Pharma (LTRN)

Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.
Market cap$34.08M
Today's volume41.03K
Revenue (TTM)
Avg. daily volume53.3K
EBITDA (TTM)-$21.11M
Open$3.14
Price / earnings ratio-1.71x
Today's range$3.09 - $3.31
Debt / equity1.16x
52 week range$2.55 - $6.12
5 year debt / equity0.2x
Beta (LTM)1.53x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio4.86x
Ex-dividend date
Next earningsAug 7, 2025
Dividend payable date

Lantern Pharma Stock Rating

What analysts recommend for LTRN stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for LTRN stock is $34.08M

The current P/E ratio for LTRN stock is -1.71

The 52-week high for LTRN stock is $6.12. The current LTRN stock price $undefined is 100.00% below its 52-week high

The 52-week low for LTRN stock is $2.55. The current LTRN stock price $undefined has increased 100.00% from its 52-week low

No, the LTRN stock does not pay dividends to its shareholders

The target price for LTRN stock is $24 based on the average of what a group of analyst think LTRN stock could be worth at a future date. This is not a prediction by Public.com

How to buy LTRN stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in LTRN stock

    Navigate to the Explore page. Then, type LTRN into the search bar. When you see LTRN stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased LTRN stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Lantern Pharma Stock Earnings

The value each LTRN share was expected to gain vs. the value that each LTRN share actually gained.

Lantern Pharma (LTRN) reported Q1 2025 earnings per share (EPS) of -$0.42, beating estimates of -$0.49 by 14.29%. In the same quarter last year, Lantern Pharma's earnings per share (EPS) was -$0.51. Lantern Pharma is expected to release next earnings on 08/07/2025, with an earnings per share (EPS) estimate of -$0.49.

Buy Lantern Pharma (LTRN) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.